Carrier Screening Market Business Scope, Industry Analysis by Top Key Players, Market trends and Insights to 2024


Carrier Screening Market Overview:

The Carrier Screening Market is estimated to reach USD 4.0 billion by 2024 from USD 1.8 billion in 2019, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection prevention of disease and technological advancements in carrier screening.

Request For Sample: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=72642285 

The expanded carrier screening segment to account for the largest share of the global carrier screening market in 2019.

On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening. The expanded carrier screening segment to account for the largest share of the global carrier screening market in 2019. The largest share of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing microarrays and recommendations for the use of expanded carrier screening.

The hospitals segment accounted for the largest share of the market in 2018.

On the basis of end user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users. In 2018, hospitals formed the largest end-user segment in the carrier screening market. The growing patient population, increase in Medicare reimbursement for clinical tests performed in hospitals, and the emergence of advanced diagnostic tests are some of the key factors driving the growth of this end-user segment.

 

Download PDF: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72642285 

Market Segmentation:

 

 

By type, the expanded carrier screening segment is expected to witness above-average growth in the carrier screening market during the forecast period.

By type, the market is segmented into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment is further segmented into predesigned panel testing and customized panel testing. The largest share of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing microarrays and recommendations for the use of expanded carrier screening.

By end user, the hospital segment is expected to grow at the highest CAGR.

On the basis of end user, the market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). The growing patient population, increase in Medicare reimbursement for clinical tests performed in hospitals, and the emergence of advanced diagnostic tests are some of the key factors driving the growth of this end-user segment.

Detailed Information:

https://www.marketsandmarkets.com/Market-Reports/carrier-screening-market-72642285.html 

Key Players:

The major companies in the carrier screening market include Eurofins Scientific (US), Invitae (US), OPKO Health (US), Fulgent Genetics (US), Quest Diagnostics (US), Sema4 (US), Myriad Genetics (US), Illumina (US), and Thermo Fisher Scientific (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]